Evidence Against a Bacterial Endotoxin Masking Effect in Biologic Drug Products by Limulus Amebocyte Lysate Detection

References

1. 1.↵
   Chapter <85> Bacterial Endotoxins Test. In United States Pharmacopeia; United States Pharmacopeial Convention: Rockville, MD, 2013.

   Google Scholar
2. 2.↵
   Chapter 2.6.14 Bacterial Endotoxins. In European Pharmacopoeia; The European Directorate for the Quality of Medicines & Health Care: Strasbourg, France, 2014.

   Google Scholar
3. 3.↵
   Chapter 4.01 Bacterial Endotoxins Test. In Japanese Pharmacopoeia; Japanese Ministry of Health, Labour and Welfare: Tokyo, Japan, 2011.

   Google Scholar
4. 4.↵
   U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry—Pyrogen and Endotoxin Testing: Questions and Answers, June 2012.

   Google Scholar
5. 5.↵
   1. Chen J.

   Low Endotoxin Recovery in Common Biologic Products. Presented at PDA 8th Annual Global Conference on Pharmaceutical Microbiology, Bethesda, MD, 2013.

   Google Scholar
6. 6.
   1. Bowers K.,
   2. Tran L.

   Creation of an in-house naturally occurring endotoxin preparation for use in endotoxin spiking studies and LAL sample hold time analysis. Am. Pharm. Rev. 2011, 14 (6).

   Google Scholar
7. 7.↵
   1. Williams K.

   Endotoxin test concerns of biologics. Am. Pharm. Rev. 2013, 16 (6).

   Google Scholar
8. 8.↵
   1. McCullough K.

   The Bacterial Endotoxins Test: A Practical Guide. PDA and Davis Healthcare International Publishing, LLC: River Grove, IL, 2011; pp 48–49.

   Google Scholar